Principal Financial Group
CGEM icon

Principal Financial Group’s Cullinan Oncology CGEM Stock Holding History

Principal Financial Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,692
Closed -$109K – 2435
2023
Q4 		$109K Sell
10,692
-181
-2% -$1.6K ﹤0.01% 2264
2023
Q3 		$98.4K Buy
10,873
+836
+8% +$8.71K ﹤0.01% 2283
2023
Q2 		$108K Sell
10,037
-173
-2% -$1.84K ﹤0.01% 2281
2023
Q1 		$104K Buy
+10,210
New +$113K ﹤0.01% 2296

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Principal Financial Group's CGEM Position: Q1 2024 in Review

Principal Financial Group sold out of Cullinan Oncology (CGEM) in Q1 2024, closing a stake of 10,692 shares — an estimated $109K sold.

Principal Financial Group first reported a position in CGEM in Q1 2023 and held it in 4 quarters. The position peaked at $109K in Q4 2023. 113 funds tracked by Wall St. Rank hold CGEM as of Q1 2024.

  • Principal Financial Group reported no remaining Cullinan Oncology position as of Q1 2024 after selling out during the quarter.
  • Principal Financial Group sold 10,692 Cullinan Oncology shares in Q1 2024, an estimated $109K.
  • Principal Financial Group first reported a position in Cullinan Oncology in Q1 2023 and held it in 4 quarters.
  • Principal Financial Group's Cullinan Oncology position peaked at $109K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2024.

Based on Principal Financial Group's 13F filing for Q1 2024, filed 29 Apr 2024.